Factors That Affect Results Delivery Route (Primary Variable) As detailed above, route selection determines more about the timeline than any other factor
Polycystic Ovary Syndrome (PCOS) - 5-10% of women 50% lower glutathione levels compared to women without PCOS 3-4x higher risk of preeclampsia 3x higher risk of gestational diabetes Critical concern: With 50% lower baseline glutathione, the "safe" dose is effectively cut in half IVF Conception - 2-5% of births (up to 6-8% in some countries) Women who conceive via IVF experience dramatic antioxidant depletion: 70% reduction in plasma antioxidant capacity 83% reduction in follicular fluid antioxidant capacity 50-100%+ increase in oxidative stress markers With over 5 million babies born via IVF globally, this represents a large high-risk population Gallbladder Dysfunction - 10% of pregnant women Up to 10% develop gallstones or biliary sludge Intrahepatic cholestasis: 0.4-10% of pregnancies CRITICAL: Fatal Outcomes Documented at Therapeutic Doses The first case of a pregnant woman with intrahepatic cholestasis who died from liver failure after taking THERAPEUTIC/NORMAL doses of acetaminophen was reported in 2022
The Mechanism With Real Numbers GHK is glycyl-L-histidyl-L-lysine, a tripeptide first isolated from human plasma by Pickart in 1973
however, p38 MAPK exerts a positive regulation on PGC1, and MAPK1 along with MAPK14 promote both starvation- and hypoxia-induced mitophagy in HeLa cells (Hirota et al., 2015)
( Calothrix parasitica (Okuda et al., 2023)
Intended strictly for laboratory research use only
